< Terug naar vorige pagina
Onderzoeker
Chantal Mathieu
- Disciplines:Endocrinologie en metabole ziekten
Affiliaties
- Klinische en Experimentele Endocrinologie (Afdeling)
Lid
Vanaf1 okt 1999 → Heden
Projecten
71 - 75 of 75
- Synthesis and evaluation of new lead vitamin D analogs for autoimmune disorders.Vanaf17 aug 2009 → 16 aug 2011Financiering: IOF - Industrieel Onderzoeksfonds
- Beckman Coulter Gallios flowcytometer.Vanaf20 okt 2008 → 19 apr 2015Financiering: Hercules - Kleine en middelzware apparatuur
- Wij slaan de brug tussen immunologisch onderzoek en klinische bed-side therapie door translationele studies in type 1 diabetes, en waar nodig in pre-klinische modellen, die beta-cellen beschermen tegen hun vernietiging.Vanaf1 sep 2008 → 31 okt 2013Financiering: Buitenl. stichtingen, fondsen e.d. met wet. oogmerk
- ActoBiotics voor antigeen-specifieke interventie in type 1 diabetes: mono- of combinatietherapie.Vanaf1 sep 2008 → 17 jul 2014Financiering: Baekeland
- Bescherming van de betacel in type 1 diabetes mellitus door beter begrip van de intracellulaire signaalcascades: interventies in pre-klinische modellen.Vanaf1 jan 2008 → 31 dec 2011Financiering: FWO Onderzoeksproject (incl. WEAVE projecten)
Publicaties
1 - 10 van 713
- Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trial.(2024)
Auteurs: Chantal Mathieu, Christophe Matthys, Annick Bogaerts, Katrien Fouzia Benhalima
Pagina's: 102523 - Continuous Glucose Monitoring-Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4.(2024)
Auteurs: Chantal Mathieu
Pagina's: 729 - 738 - The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review(2024)
Auteurs: Chantal Mathieu, Pieter Gillard
Pagina's: 66 - 75 - CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.(2024)
Auteurs: Rita Derua, Chantal Mathieu, Lut Overbergh
Pagina's: db230588 - The double burden: Navigating type 1 diabetes and obesity(2024)
Auteurs: Nele Steenackers, Chantal Mathieu, Bart Van Der Schueren
- Type 1 diabetes mellitus: a brave new world(2024)
Auteurs: Chantal Mathieu
Pagina's: 71 - 72 - Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes(2024)
Auteurs: Kristina Casteels, Chantal Mathieu
- An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes.(2024)
Auteurs: Chantal Mathieu, Lut Overbergh
Pagina's: db230622 - A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab(2024)
Auteurs: Chantal Mathieu
- Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes(2023)
Auteurs: Lieven Dupont, Natalie Lorent, Pieter Gillard, Bart Van Der Schueren, Ann Mertens, Chantal Mathieu, Roman Vangoitsenhoven
Patenten
1 - 6 van 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)